443 related articles for article (PubMed ID: 30539290)
1. Identification of salivary metabolites for oral squamous cell carcinoma and oral epithelial dysplasia screening from persistent suspicious oral mucosal lesions.
Ishikawa S; Wong DTW; Sugimoto M; Gleber-Netto FO; Li F; Tu M; Zhang Y; Akin D; Iino M
Clin Oral Investig; 2019 Sep; 23(9):3557-3563. PubMed ID: 30539290
[TBL] [Abstract][Full Text] [Related]
2. Discrimination of oral squamous cell carcinoma from oral lichen planus by salivary metabolomics.
Ishikawa S; Sugimoto M; Edamatsu K; Sugano A; Kitabatake K; Iino M
Oral Dis; 2020 Jan; 26(1):35-42. PubMed ID: 31602722
[TBL] [Abstract][Full Text] [Related]
3. Salivary metabolomics for oral leukoplakia with and without dysplasia.
Kitabatake K; Ishikawa S; Sugimoto M; Enomoto A; Kaneko M; Ota S; Edamatsu K; Yusa K; Hemmi T; Okuyama N; Iino M
J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101618. PubMed ID: 37659754
[TBL] [Abstract][Full Text] [Related]
4. Salivary Interleukin Levels in Oral Squamous Cell Carcinoma and Oral Epithelial Dysplasia: Findings from a Sri Lankan Study.
Piyarathne NS; Weerasekera MM; Fonseka PFD; Karunatilleke AHTS; Liyanage RLPR; Jayasinghe RD; De Silva K; Yasawardene S; Gupta E; Jayasinghe JAP; Abu-Eid R
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900301
[TBL] [Abstract][Full Text] [Related]
5. Investigation and identification of potential biomarkers in human saliva for the early diagnosis of oral squamous cell carcinoma.
Wang Q; Gao P; Wang X; Duan Y
Clin Chim Acta; 2014 Jan; 427():79-85. PubMed ID: 24144867
[TBL] [Abstract][Full Text] [Related]
6. Salivary microRNAs in oral cancer.
Zahran F; Ghalwash D; Shaker O; Al-Johani K; Scully C
Oral Dis; 2015 Sep; 21(6):739-47. PubMed ID: 25784212
[TBL] [Abstract][Full Text] [Related]
7. "Salivary LINC00657 and miRNA-106a as diagnostic biomarkers for oral squamous cell carcinoma, an observational diagnostic study".
Tarrad NAF; Hassan S; Shaker OG; AbdelKawy M
BMC Oral Health; 2023 Dec; 23(1):994. PubMed ID: 38087258
[TBL] [Abstract][Full Text] [Related]
8. Salivary Biomarkers for Detection of Oral Squamous Cell Carcinoma in a Taiwanese Population.
Gleber-Netto FO; Yakob M; Li F; Feng Z; Dai J; Kao HK; Chang YL; Chang KP; Wong DT
Clin Cancer Res; 2016 Jul; 22(13):3340-7. PubMed ID: 26847061
[TBL] [Abstract][Full Text] [Related]
9. Biological significance of 5-hydroxymethylcytosine in oral epithelial dysplasia and oral squamous cell carcinoma.
Cuevas-Nunez MC; Gomes CBF; Woo SB; Ramsey MR; Chen XL; Xu S; Xu T; Zhan Q; Murphy GF; Lian CG
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jan; 125(1):59-73.e2. PubMed ID: 28743666
[TBL] [Abstract][Full Text] [Related]
10. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
[TBL] [Abstract][Full Text] [Related]
11. Point-of-care Analysis for Non-invasive Diagnosis of Oral cancer (PANDORA): A technology-development proof of concept diagnostic accuracy study of dielectrophoresis in patients with oral squamous cell carcinoma and dysplasia.
Hughes MP; Labeed FH; Hoettges KF; Porter S; Mercadante V; Kalavrezos N; Liew C; McCaul JA; Kulkarni R; Cymerman J; Kerawala C; Barber J; Lewis MP; Fedele S
J Oral Pathol Med; 2023 Apr; 52(4):305-314. PubMed ID: 36811206
[TBL] [Abstract][Full Text] [Related]
12. Nucleus Accumbens-Associated Protein 1 Expression Has Potential as a Marker for Distinguishing Oral Epithelial Dysplasia and Squamous Cell Carcinoma.
Sekine J; Nakatani E; Ohira K; Hideshima K; Kanno T; Nariai Y; Kagimura T; Urano T
PLoS One; 2015; 10(7):e0131752. PubMed ID: 26172271
[TBL] [Abstract][Full Text] [Related]
13. Salivary Circular RNAs Hsa_Circ_0001874 and Hsa_Circ_0001971 as Novel Biomarkers for the Diagnosis of Oral Squamous Cell Carcinoma.
Zhao SY; Wang J; Ouyang SB; Huang ZK; Liao L
Cell Physiol Biochem; 2018; 47(6):2511-2521. PubMed ID: 29991057
[TBL] [Abstract][Full Text] [Related]
14. Peroxiredoxin-2 and zinc-alpha-2-glycoprotein as potentially combined novel salivary biomarkers for early detection of oral squamous cell carcinoma using proteomic approaches.
Heawchaiyaphum C; Pientong C; Phusingha P; Vatanasapt P; Promthet S; Daduang J; Teeramatwanich W; Kongyingyoes B; Chuerduangphui J; Ekalaksananan T
J Proteomics; 2018 Feb; 173():52-61. PubMed ID: 29199150
[TBL] [Abstract][Full Text] [Related]
15. Salivary MMP-9 in the detection of oral squamous cell carcinoma.
Peisker A; Raschke GF; Fahmy MD; Guentsch A; Roshanghias K; Hennings J; Schultze-Mosgau S
Med Oral Patol Oral Cir Bucal; 2017 May; 22(3):e270-275. PubMed ID: 28160595
[TBL] [Abstract][Full Text] [Related]
16. Salivary metabolite signatures of oral cancer and leukoplakia.
Wei J; Xie G; Zhou Z; Shi P; Qiu Y; Zheng X; Chen T; Su M; Zhao A; Jia W
Int J Cancer; 2011 Nov; 129(9):2207-17. PubMed ID: 21190195
[TBL] [Abstract][Full Text] [Related]
17. Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
Momen-Heravi F; Trachtenberg AJ; Kuo WP; Cheng YS
J Dent Res; 2014 Jul; 93(7 Suppl):86S-93S. PubMed ID: 24718111
[TBL] [Abstract][Full Text] [Related]
18. Malignant transformation of oral epithelial dysplasia in Southwest Finland.
Nevanpää TT; Terävä AE; Laine HK; Rautava J
Sci Rep; 2022 May; 12(1):8261. PubMed ID: 35585112
[TBL] [Abstract][Full Text] [Related]
19. Clinical value of Naa10p and CEA levels in saliva and serum for diagnosis of oral squamous cell carcinoma.
Zheng J; Sun L; Yuan W; Xu J; Yu X; Wang F; Sun L; Zeng Y
J Oral Pathol Med; 2018 Oct; 47(9):830-835. PubMed ID: 30028540
[TBL] [Abstract][Full Text] [Related]
20. p53 and p16 in oral epithelial dysplasia and oral squamous cell carcinoma: A study of 208 cases.
Cuevas Gonzalez JC; Gaitan Cepeda LA; Borges Yanez SA; Cornejo AD; Mori Estevez AD; Huerta ER
Indian J Pathol Microbiol; 2016; 59(2):153-8. PubMed ID: 27166031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]